Cargando…

The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020)

BACKGROUND: Chronic pain is a common disease; about 20% of people worldwide suffer from it. While compared with the research on the prevalence and management of chronic pain in developed countries, there is a relative lack of research in this field in China. This research aims to construct the China...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yingying, Xu, Tingling, Mao, Fan, Miao, Yu, Liu, Botao, Xu, Liyuan, Li, Lingni, Sternbach, Nikoletta, Zhou, Maigeng, Fan, Bifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636663/
https://www.ncbi.nlm.nih.gov/pubmed/36333770
http://dx.doi.org/10.1186/s12963-022-00297-0
_version_ 1784824998205063168
author Jiang, Yingying
Xu, Tingling
Mao, Fan
Miao, Yu
Liu, Botao
Xu, Liyuan
Li, Lingni
Sternbach, Nikoletta
Zhou, Maigeng
Fan, Bifa
author_facet Jiang, Yingying
Xu, Tingling
Mao, Fan
Miao, Yu
Liu, Botao
Xu, Liyuan
Li, Lingni
Sternbach, Nikoletta
Zhou, Maigeng
Fan, Bifa
author_sort Jiang, Yingying
collection PubMed
description BACKGROUND: Chronic pain is a common disease; about 20% of people worldwide suffer from it. While compared with the research on the prevalence and management of chronic pain in developed countries, there is a relative lack of research in this field in China. This research aims to construct the China Pain Health Index (CPHI) to evaluate the current status of the prevalence and management of chronic pain in the Chinese population. METHODS: The dimensions and indicators of CPHI were determined through literature review, Delphi method, and analytical hierarchy process model, and the original values ​​of relevant indicators were obtained by collecting multi-source data. National and sub-provincial scores of CPHI (2020) were calculated by co-directional transformation, standardization, percentage transformation of the aggregate, and weighted summation. RESULTS: The highest CPHI score in 2020 is Beijing, and the lowest is Tibet. The top five provinces are Beijing (67.64 points), Shanghai (67.04 points), Zhejiang (65.74 points), Shandong (61.16 points), and Tianjin (59.99 points). The last five provinces are Tibet (33.10 points), Ningxia (37.24 points), Guizhou (39.85 points), Xinjiang (39.92 points), and Hainan (40.38 points). The prevalence of chronic pain is severe in Heilongjiang, Chongqing, Guizhou, Sichuan, and Fujian. Guizhou, Hainan, Xinjiang, Beijing, and Guangdong display a high burden of chronic pain. The five provinces of Guangdong, Shanghai, Beijing, Jiangsu, and Zhejiang have better treatment for chronic pain, while Tibet, Qinghai, Jilin, Ningxia, and Xinjiang have a lower quality of treatment. Beijing, Shanghai, Qinghai, Guangxi, and Hunan have relatively good development of chronic pain disciplines, while Tibet, Sichuan, Inner Mongolia, Hebei, and Guizhou are relatively poor. CONCLUSION: The economically developed provinces in China have higher CPHI scores, while economically underdeveloped areas have lower scores. The current pain diagnosis and treatment situation in economically developed regions is relatively good, while that in financially underdeveloped areas is rather poor. According to the variations in the prevalence and management of chronic pain among populations in different provinces in China, it is necessary to implement chronic pain intervention measures adapted to local conditions.
format Online
Article
Text
id pubmed-9636663
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96366632022-11-06 The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020) Jiang, Yingying Xu, Tingling Mao, Fan Miao, Yu Liu, Botao Xu, Liyuan Li, Lingni Sternbach, Nikoletta Zhou, Maigeng Fan, Bifa Popul Health Metr Research BACKGROUND: Chronic pain is a common disease; about 20% of people worldwide suffer from it. While compared with the research on the prevalence and management of chronic pain in developed countries, there is a relative lack of research in this field in China. This research aims to construct the China Pain Health Index (CPHI) to evaluate the current status of the prevalence and management of chronic pain in the Chinese population. METHODS: The dimensions and indicators of CPHI were determined through literature review, Delphi method, and analytical hierarchy process model, and the original values ​​of relevant indicators were obtained by collecting multi-source data. National and sub-provincial scores of CPHI (2020) were calculated by co-directional transformation, standardization, percentage transformation of the aggregate, and weighted summation. RESULTS: The highest CPHI score in 2020 is Beijing, and the lowest is Tibet. The top five provinces are Beijing (67.64 points), Shanghai (67.04 points), Zhejiang (65.74 points), Shandong (61.16 points), and Tianjin (59.99 points). The last five provinces are Tibet (33.10 points), Ningxia (37.24 points), Guizhou (39.85 points), Xinjiang (39.92 points), and Hainan (40.38 points). The prevalence of chronic pain is severe in Heilongjiang, Chongqing, Guizhou, Sichuan, and Fujian. Guizhou, Hainan, Xinjiang, Beijing, and Guangdong display a high burden of chronic pain. The five provinces of Guangdong, Shanghai, Beijing, Jiangsu, and Zhejiang have better treatment for chronic pain, while Tibet, Qinghai, Jilin, Ningxia, and Xinjiang have a lower quality of treatment. Beijing, Shanghai, Qinghai, Guangxi, and Hunan have relatively good development of chronic pain disciplines, while Tibet, Sichuan, Inner Mongolia, Hebei, and Guizhou are relatively poor. CONCLUSION: The economically developed provinces in China have higher CPHI scores, while economically underdeveloped areas have lower scores. The current pain diagnosis and treatment situation in economically developed regions is relatively good, while that in financially underdeveloped areas is rather poor. According to the variations in the prevalence and management of chronic pain among populations in different provinces in China, it is necessary to implement chronic pain intervention measures adapted to local conditions. BioMed Central 2022-11-04 /pmc/articles/PMC9636663/ /pubmed/36333770 http://dx.doi.org/10.1186/s12963-022-00297-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jiang, Yingying
Xu, Tingling
Mao, Fan
Miao, Yu
Liu, Botao
Xu, Liyuan
Li, Lingni
Sternbach, Nikoletta
Zhou, Maigeng
Fan, Bifa
The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020)
title The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020)
title_full The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020)
title_fullStr The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020)
title_full_unstemmed The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020)
title_short The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020)
title_sort prevalence and management of chronic pain in the chinese population: findings from the china pain health index (2020)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636663/
https://www.ncbi.nlm.nih.gov/pubmed/36333770
http://dx.doi.org/10.1186/s12963-022-00297-0
work_keys_str_mv AT jiangyingying theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT xutingling theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT maofan theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT miaoyu theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT liubotao theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT xuliyuan theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT lilingni theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT sternbachnikoletta theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT zhoumaigeng theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT fanbifa theprevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT jiangyingying prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT xutingling prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT maofan prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT miaoyu prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT liubotao prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT xuliyuan prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT lilingni prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT sternbachnikoletta prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT zhoumaigeng prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020
AT fanbifa prevalenceandmanagementofchronicpaininthechinesepopulationfindingsfromthechinapainhealthindex2020